Contact
Please use this form to send email to PR contact of this press release:
Atelerix Life Sciences Announces Publication Demonstrating Reversal of Opioid Induced Respiratory Depression
TO:
David Gregory Kalergis
Atelerix Life Sciences Inc.
+1 434-825-1834